Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.42 |
| ▸ | CALCR | P30988 | 3/20 | 0.42 |
| ▸ | FNTA | P49354 | 10/20 | 0.40 |
| ▸ | FNTB | P49356 | 10/20 | 0.40 |
| ▸ | PGGT1B | P53609 | 6/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL415551 | 1.00 | APLNR (0.42) | APLNRCALCRFNTAFNTBPGGT1B | |
| SCHEMBL412324 | 0.97 | APLNR (0.42) | APLNRCALCRFNTAFNTBPGGT1B | |
| SCHEMBL412323 | 0.97 | APLNR (0.42) | APLNRCALCRFNTAFNTBPGGT1B | |
| SCHEMBL414400 | 0.95 | APLNR (0.41) | APLNRCALCRFNTAFNTBPGGT1B | |
| SCHEMBL414401 | 0.95 | APLNR (0.41) | APLNRCALCRFNTAFNTBPGGT1B | |
| SCHEMBL416409 | 0.90 | OPRM1 (0.39) | APLNR | |
| SCHEMBL416410 | 0.90 | OPRM1 (0.39) | APLNR | |
| SCHEMBL31256943 | 0.84 | OPRM1 (0.42) | — | |
| SCHEMBL29519342 | 0.84 | APLNR (0.40) | APLNR | |
| SCHEMBL29616320 | 0.83 | FNTA (0.45) | FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120020878-A1 | FUSOGENIC PROPERTIES OF SAPOSIN C AND RELATED PROTEINS AND PEPTIDES FOR APPLICATION TO TRANSMEMBRANE DRUG DELIVERY SYSTEMS | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2012-01-26 | — | — | US | disclosed |
| CN-102264349-A | Sphingolipid activator protein C and related protein and peptide fusogenic properties for transmembrane drug delivery systems | — | 2011-11-30 | — | — | CN | disclosed |
| EP-2365796-A1 | FUSOGENIC PROPERTIES OF SAPOSIN C AND RELATED PROTEINS AND PEPTIDES FOR APPLICATION TO TRANSMEMBRANE DRUG DELIVERY SYSTEMS | Children's Hospital Medical Center (US) | 2011-09-21 | — | — | EP | disclosed |
| WO-2010053489-A1 | FUSOGENIC PROPERTIES OF SAPOSIN C AND RELATED PROTEINS AND PEPTIDES FOR APPLICATION TO TRANSMEMBRANE DRUG DELIVERY SYSTEMS | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2010-05-14 | — | — | WO | disclosed |